Methods for embolizing blood vessels

• US 6,017,977 A
• Filed: 06/04/1997
• Issued: 01/25/2000
• Est. Priority Date: 01/31/1996
• Status: Expired due to Term

• Current Assignee: Micro Therapeutics, Inc. (Medtronic Plc)
• Original Assignee: Micro Therapeutics, Inc. (Medtronic Plc)
• Inventors: Greff, Richard, Evans, Scott, Perl, John II
• Primary Examiner(s): MERRIAM, ANDREW EDWIN
• Application Number:
  US08/868,931
• Time in Patent Office: 965 Days
• Field of Search: 523/105, 523/113, 523/222, 424/9.1, 424/9.411, 424/9.42, 424/649, 524/173, 524/440, 604/53
• US Class Current: 523/113
• CPC Class Codes: A61L 2300/418 Agents promoting blood coagulation, blood-clotting agents, embolising agents
• CPC Class Codes: A61L 2300/44 Radioisotopes, radionuclides
• CPC Class Codes: A61L 24/001 Use of materials characterised by their function or physical properties
• CPC Class Codes: A61L 24/0015 Medicaments; Biocides
• CPC Class Codes: A61L 24/02 containing inorganic materials
• CPC Class Codes: A61L 24/04 containing macromolecular materials
• CPC Class Codes: A61L 2430/36 for embolization or occlusion, e.g. vaso-occlusive compositions or devices
• CPC Class Codes: A61L 31/02 Inorganic materials
• CPC Class Codes: A61P 13/02 of urine or of the urinary tract, e.g. urine acidifiers
• CPC Class Codes: A61P 15/00 Drugs for genital or sexual disorders for disorders of sex hormones A61P5/24; Contraceptives
• CPC Class Codes: A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• CPC Class Codes: A61P 9/14 Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Abstract

Disclosed are methods useful for treating vascular lesions wherein a non-particulate agent such as a metal coil is introduced into a vascular site (e.g., an aneurysm cavity) in conjunction with an embolizing composition comprising a biocompatible polymer and a biocompatible solvent.

The biocompatible solvent is miscible or soluble in blood and also solubilizes the polymer during delivery. The biocompatible polymer is selected to be soluble in the biocompatible solvent but insoluble in blood. Upon contact with the blood, the biocompatible solvent dissipates from the embolic composition whereupon the biocompatible polymer precipitates. Precipitation of the polymer in the presence of the non-particulate agent permits the agent to act as a structural lattice for the growing polymer precipitate.

In another embodiment, the biocompatible polymer composition can be replaced with a biocompatible prepolymer composition containing a biocompatible prepolymer.

Claims

1. A kit of parts comprising:

(a) a polymer composition comprising a biocompatible polymer, a biocompatible solvent which is selected from an organic material liquid at least at body temperature of a mammal in which the biocompatible polymer is soluble and a contrast agent which is capable of being monitored during injection into the mammal by radiography; and

(b) a non-particulate agent or plurality of such agents wherein said agents are selected from the group consisting of metallic coils, coils with barbs, silk streamers, plastic brushes, detachable balloons, foam and nylon mesh

wherein said polymer composition comprises a sufficient amount of said polymer such that, upon discharge into a vascular site, a solid mass precipitates in the presence of the non-particulate agent to embolize said vascular site.

2. The kit of parts according to claim 1 wherein said biocompatible solvent is selected from the group consisting of dimethylsulfoxide, ethanol, and acetone.

3. The kit of parts according to claim 2 wherein said biocompatible solvent is DMSO.

4. The kit of parts according to claim 1 wherein said contrast agent is a water insoluble contrast agent.

5. The kit of parts according to claim 4 wherein said water insoluble contrast agent is selected from the group consisting of tantalum, tantalum oxide, tungsten and barium sulfate.

6. The kit of parts according to claim 1 wherein said contrast agent is a water soluble contrast agent.

7. The kit of parts according to claim 6 wherein said water soluble contrast agent is 2-((3-(acetylamino)-5-(acetylmethylamino)-2,4,6-triiodobenzoyl)aminol)-2-deoxy-D-glucose.

8. The kit of parts according to claim 1 wherein said non-particulate agent is a metallic coil or a plurality of metallic coils.

9. The kit of parts according to claim 8 wherein said metallic coil is a platinum coil.

10. The kit of parts according to claim 1 wherein the kit further comprises a catheter capable of delivering said polymer composition.

11. The kit of parts according to claim 10 wherein the catheter capable of delivering said polymer composition is also capable of delivering said non-particulate agent.

12. The kit of parts according to claim 10 which further comprises a catheter capable of delivering said non-particulate agent.